Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · April 17, 2022

Pilot Clinical Study to Evaluate Liraglutide-Mediated Anti-Platelet Activity in Patients With Type-2 Diabetes

Journal of Diabetes and its Complications


Additional Info

Journal of Diabetes and its Complications
A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study)
J Diabetes Complicat 2022 Mar 30;[EPub Ahead of Print], J Loganathan, AC Cohen, GM Kaloupis, C Harris, A Chronopoulos, V James, J Hamilton, S Green, A Wallis, S Morgan, R Dauer, C Gilfillan, AE Dear

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading